Ivermectin Intended for Animals: Letter to Stakeholders – Do Not Use in Humans as a Treatment for COVID-19 (2020)

Government Record · U.S. Food and Drug Administration, Office of the Commissioner · April 10, 2020

U.S. Food et al., 2020-04-10: FDA stakeholder letter warning against using animal ivermectin products in people. It states ivermectin is FDA-approved for animal uses and that animal drugs have been evaluated only in the species on their labels.

Ivermectin is FDA-approved for use in animals for prevention of heartworm disease in some small animal species, and for treatment of certain internal and external parasites in various animal species.

U.S. Food et al., 2020-04-10: FDA stakeholder letter warning against using animal ivermectin products in people. It states ivermectin is FDA-approved for animal uses and that animal drugs have been evaluated only in the species on their labels. F2. Document type: agency safety communication (no study, no subjects). This is the only FDA text located in this run that says in terms that ivermectin is 'FDA-approved for use in animals', which is the closest thing to the book's 'classified by the FDA as a veterinary drug' (book L2610). It does not say the drug is a veterinary drug for cancer or that human ivermectin is a veterinary product; the same letter tells people not to take 'any form of ivermectin unless it has been prescribed by a licensed health care provider', presupposing an approved human medicine. Nothing in it mentions cancer. Study type: regulatory record.